Press Release

Medication Adherence Devices Market to be Dominated by Software Centric through 2028

The increasing incidence of chronic diseases is expected to drive the growth of Global Medication Adherence Devices Market in the forecast period, 2024-2028.


According to TechSci Research report, “Medication Adherence Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028,” the Global Medication Adherence Devices Market is anticipated to grow at an impressive rate in the forecast period, 2024-2028. This can be ascribed to the growing demand for advanced medication adherence systems along with the growing prevalence of chronic diseases across the globe. Additionally, the growing geriatric population and growing demand for mHealth technologies for observing and imposing adherence to the medical plan are expected to create significant growth during the forecast period
. Besides, the growing demand for personalized healthcare and the growing usage of pharmaceuticals in the developing regions will further boost the growth of the market during the forecast period. Similarly, the growing demand for home healthcare services and the growing adoption of smart technology related to medicine will further propel the growth of the market during the forecast period. Also, the availability, as well as affordability of medicine, has increased which will further drive the growth of the market in the forecast period.  

However, the lack of healthcare infrastructure and growing patient privacy may slow down the growth of the global medication adherence devices market in the forecast period. Also, myths and misconceptions associated with medical adherence can further restrict the growth of the global medication adherence devices market. Similarly, the uncertainties about reimbursement procedures for the treatment of chronic diseases can further restrict the growth of the market during the forecast period.


Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Medication Adherence Devices Market"


Global Medication Adherence Devices market can be segmented based on type, medication, region and competitional landscape.

Based on the type, the global medication adherence devices market can be divided into hardware centric and software centric. The software-centric segment dominated the market in 2022 and is expected to continue maintaining its dominance throughout the forecast period. This can be ascribed to the growing demand for easy-to-use applications which will help track all records and intimate the patient and also the respective caregiver of his or her medication compliance. Also, the growing development of new mobile applications over the years and app-based medication adherence products will boost the demand for the market.

Based on Medication, the market can be segmented into cardiovascular, central nervous system, diabetes, oncology, gastrointestinal, musculoskeletal, others. The cardiovascular diseases segment is expected to dominate during the forecast period on account of the increasing prevalence of cardiovascular diseases along with the unhealthy lifestyle among the population. Also, the high prevalence of medication non-adherence by heart patients is expected to drive the growth of the market during the forecast period.

Major companies operating in the Global Medication Adherence Devices market are:

  • Becton, Dickinson and Company (CareFusion)
  • DrFirst.com,Inc.
  • AdhereTech Inc.
  • MedMinder.
  • Caredose.
  • Fruitech Ltd.
  • PHC Holdings Corporation.
  • MedAdvisor International Pty Ltd.


uMotif Limited, in September 2020, announced that it has raised around USD6.4 million in the series A investment round. This funding was led by existing investor AlbionVC. The raised funds would be used for the development of its patient-centric and decentralized approach to clinical studies and enable expansion into new study types and more high-demand territories.

HealthBeacon Limited raised USD12 million in the series A investment round in January 2019. This funding brought the total investment to be around USD15 million. The round was led by Oyster Capital and Elkstone Partners.


Download Free Sample Report

Customers can also request for 10% free customization on this report.


“North America is expected to dominate the Global Medication Adherence Devices Market on account of growing research and development in the healthcare sector along with the growing aging population across the region. Similarly, growing healthcare expenditure and increasing incidence of chronic diseases such as cardiovascular diseases can further enhance the demand for medication adherence devices, which will boost the market growth during the forecast period. Also, growing disposable income helps patients treat chronic diseases at a high cost which will further drive market growth over the years. Furthermore, the growing demand for web-based health tech solutions for tracking all the data related to treatment in the hospital sectors is further contributing to the demand for the medication adherence market in the forecast period. Besides, the growing number of new companies in the market is further expected to create lucrative opportunities for market growth,” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based global management consulting firm.

“Medication Adherence Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Type (Hardware Centric v/s Software Centric), By Medication (Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal, Others), By Region and Competition”, has evaluated the future growth potential of global medication adherence devices market and provides statistics & information on market size, structure, and future market growth. The report intends to provide cutting-edge market intelligence and help decision-makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in the global medication adherence devices market.


Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com

Relevant News